AIQ SOLUTIONS WILL BE ATTENDING IN-PERSON IO360 2022

Post author By AIQ847llIovj
Post date February 15, 2022

Immuno-Oncology 360 2022 March 16-18, 2022 New York Marriott Brooklyn Bridge

AIQ's software has been cleared for clinical use under 510(k) K233998. For details, including the applicable Indications for Use, see: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K233998